InMed Pharmaceuticals Inc. Appoints Martin Bott to the Board of Directors
January 13, 2017 at 03:42 pm EST
InMed Pharmaceuticals Inc. announced that Martin Bott, VP of Corporate Finance and Investment Banking at Eli Lilly &Company, has been appointed to the company's Board of Directors effective immediately. Mr. Bott brings over 28 years of senior financial and executive leadership to the company's Board of Directors. Martin Bott has established a significant leadership position in financial and business expertise.